Publications

Publications 14926 - 14950 de 33557
| % | ( | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | < | ? | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | [ | ` | {
Titre DOI
Hypermetabolism of the spleen or bone marrow is an additional albeit indirect sign of infective endocarditis at FDG-PET
C. Boursier; X. Duval; B. Mahida; B. Hoen; F. Goehringer; C. Selton-Suty; E. Chevalier; V. Roch; Z. Lamiral; A. Bourdon; N. Piriou; A. Pallardy; O. Morel; F. Rouzet; P.Y. Marie; A.E.P.E.I.T.E.P.E.N.D.O.Study Grp
Submitted
10.1007/s12350-020-02050-2, Early Access Date = {FEB 2020
Hyperoxemia and Veno-Arterial Extracorporeal Membrane Oxygenation: Do Not Forget the Gut
H. Winiszewski; G. Piton; A. Perrotti; G. Capellier
2018
10.1097/CCM.0000000000002750
Hyperoxia during cardiopulmonary bypass does not decrease cardiovascular complications following cardiac surgery: the CARDIOX randomized clinical trial
O. Abou-Arab; P. Huette; L. Martineau; C. Beauvalot; C. Beyls; E. Josse; G. Touati; O. Bouchot; B. Bouhemad; M. Diouf; E. Lorne; P.G. Guinot
2019
10.1007/s00134-019-05761-4
Hyperoxia during cardiopulmonary bypass does not increase respiratory or neurological complications: a post hoc analysis of the CARDIOX study
O. Abou-Arab; P. Huette; M. Guilbart; H. Dupont; P.G. Guinot
2020
10.1016/j.bja.2020.06.031
Hyperphagia in short bowel patients: Fat-free mass is a strong predictor
C. Betry; M. Lauverjat; T. Mouillot; C. Bergoin; D. Barnoud; S. Ait; C. Chambrier
2019
10.1016/j.nut.2018.12.013
Hyperprogressive Disease (HPD) Is Frequent in Non-Small Cell Lung Cancer (NSCLC) Patients (Pts) Treated with Anti PD1/PD-L1 Agents (IO)
R. Ferrara; C. Caramella; M. Texier; C. Audigier-Valette; L. Tessonnier; L. Mezquita; J. Lahmar; J. Mazieres; G. Zalcman; S. Brosseau; V. Westeel; S. Le Moulec; L. Leroy; B. Duchemann; C. Lefebvre; R. Veillon; S. Champiat; C. Ferte; D. Planchard; M. Boucher; G. Martinez-Bernal; E. Bria; G. Tortora; J. Soria; B. Besse
2017
10.1016/j.jtho.2017.09.541
Hyperprogressive disease (HPD) is frequent in non-small cell lung cancer (NSCLC) patients (pts) treated with anti PD1/PD-L1 monoclonal antibodies (IO)
R. Ferrara; C. Caramella; M. Texier; A. Valette; L. Tessonnier; L. Mezquita; J. Lahmar; J. Mazieres; G. Zalcman; S. Brosseau; V. Westeel; S. Le Moulec; L. Leroy; B. Duchemann; R. Veillon; D. Planchard; M.E. Boucher; S. Koscielny; J.C. Soria; B. Besse
2017
Hyperprogressive disease (HPD) is frequent in non-small cell lung cancer (NSCLC) patients (pts) treated with anti PD1/PD-L1 monoclonal antibodies (IO)
R. Ferrara; C. Caramella; M. Texier; A. Valette; L. Tessonnier; L. Mezquita; J. Lahmar; J. Mazieres; G. Zalcman; S. Brosseau; V. Westeel; S. Le Moulec; L. Leroy; B. Duchemann; R. Veillon; D. Planchard; M.E. Boucher; S. Koscielny; J.C. Soria; B. Besse
2017
Hypersensitivity pneumonitis in a beautician
T. Soumagne; G. Reboux; B. Degano; J.Charles Dalphin
2016
10.1002/ajim.22628
Hypersensitivity pneumonitis in a cystic fibrosis patient
A.P. Bellanger; H. Morisse-Pradier; G. Reboux; E. Scherer; S. Pramil; S. Dominique; L. Millon
2019
10.1093/occmed/kqz115
Hypersensitivity pneumonitis in children
T. Soumagne; M.L. Dalphin; J.C. Dalphin
2019
10.1016/j.rmr.2018.06.010
Hypersensitivity pneumonitis: A new strategy for serodiagnosis and environmental surveys
A.P. Bellanger; G. Reboux; A. Rouzet; C. Barrera; S. Rocchi; E. Scherer; L. Millon
2019
10.1016/j.rmed.2019.02.019
Hyperspectral core logging for fire reconstruction studies
A. Van Exem; M. Debret; Y. Copard; B. Vanniere; P. Sabatier; S. Marcotte; B. Laignel; J.L. Reyss; M. Desmet
2018
10.1007/s10933-017-0009-5
Hyperspectral near-field imaging of light bending in a graded photonic crystal
B. Cluzel; J. Dellinger; K.V. Do; E. Cassan; F. de Fornel
2014
Hyperspectral Texture Metrology Based on Joint Probability of Spectral and Spatial Distribution
R.Jian Chu; N. Richard; H. Chatoux; C. Fernandez-Maloigne; J.Yngve Hardeberg
2021
10.1109/TIP.2021.3071557
Hyperspectral venous image quality assessment for optimum illumination range selection based on skin tone characteristics
A. Shahzad; M.Naufal Saad; N. Walter; A.Saeed Malik; F. Meriaudeau
2014
10.1186/1475-925X-13-109
Hypertension induced by serotonin reuptake inhibitors: analysis of two pharmacovigilance databases
X. Humbert; S. Fedrizzi; B. Chretien; M. Sassier; H. Bagheri; S. Combret; M.D. Drici; F. Le Bas; P.E. Puddu; J. Alexandre
2019
10.1111/fcp.12440
Hyperthermia restores apoptosis induced by death receptors through aggregation-induced c-FLIP cytosolic depletion
A. Morle; C. Garrido; O. Micheau
2015
10.1038/cddis.2015.12
Hyperthyroidism induced by dipotassium clorazepate: a case study
J. Gillet; E. Blaise; J.C. Chauvet-Gelinier; B. Bonin
2014
10.1016/j.eurpsy.2014.09.030
Hypertonic Lactate to Improve Cerebral Perfusion and Glucose Availability After Acute Brain Injury
L. Carteron; D. Solari; C. Patet; H. Quintard; J.P. Miroz; J. Bloch; R.T. Daniel; L. Hirt; P. Eckert; P.J. Magistretti; M. Oddo
2018
10.1097/CCM.0000000000003274
Hypertriglyceridemia in diabetes
B. Verges
2020
Hypertriglyceridemia in diabetes
B. Verges
2020
Hypnosis as an effective management of a child with posttraumatic stress disorder after perineal trauma
M.A. Mubiri; M. Peycelon; G. Audry; F. Auber
2014
10.1016/j.arcped.2014.03.019
Hypofractionated stereotactic radiotherapy as a salvage therapy for recurrent high-grade gliomas
T. Reynaud; N. Vulquin; W. Farah; D. Thibouw; G. Crehange; A. Bertaut; G. Truc
2018
10.1016/S0167-8140(18)31509-3
Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience
T. Reynaud; A. Bertaut; W. Farah; D. Thibouw; G. Crehange; G. Truc; N. Vulquin
2018
10.1177/1533033818806498

Pages